Palatin Technologies - 23 Year Stock Price History | PTN

Historical daily share price chart and data for Palatin Technologies since 1997 adjusted for splits. The latest closing stock price for Palatin Technologies as of January 24, 2020 is 0.70.
  • The all-time high Palatin Technologies stock closing price was 96.30 on October 17, 1997.
  • The Palatin Technologies 52-week high stock price is 1.78, which is 154.3% above the current share price.
  • The Palatin Technologies 52-week low stock price is 0.66, which is 5.7% below the current share price.
  • The average Palatin Technologies stock price for the last 52 weeks is 0.96.
Palatin Technologies Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 0.7306 0.7900 0.7900 0.6857 0.6981 -10.75%
2019 0.9616 0.7706 1.6400 0.6735 0.7822 10.42%
2018 0.9873 0.8400 1.4500 0.6308 0.7084 -17.52%
2017 0.5216 0.5490 1.0000 0.3000 0.8589 70.05%
2016 0.5363 0.6800 0.8200 0.3911 0.5051 -23.93%
2015 0.8710 0.8000 1.2700 0.6200 0.6640 -9.04%
2014 0.9697 0.7400 1.4400 0.6100 0.7300 -0.54%
2013 0.6416 0.6170 0.7820 0.5510 0.7340 22.35%
2012 0.6228 0.4203 0.7900 0.4203 0.5999 49.27%
2011 0.8409 1.4000 1.4000 0.4019 0.4019 -70.23%
2010 2.1510 3.4740 3.5000 0.8900 1.3500 -63.46%
2009 2.3024 1.0000 4.0000 0.7000 3.6950 311.01%
2008 1.9483 2.1000 4.2000 0.6060 0.8990 -55.05%
2007 14.1347 20.0000 23.3000 1.9000 2.0000 -90.20%
2006 25.1450 31.9000 37.2000 17.4000 20.4000 -37.42%
2005 22.8675 25.6000 40.3000 17.0000 32.6000 22.56%
2004 33.2456 26.7000 43.0000 23.5000 26.6000 6.40%
2003 28.9002 19.0000 58.6000 12.9000 25.0000 26.26%
2002 24.0992 40.0000 40.9000 11.0000 19.8000 -52.86%
2001 38.8785 36.2500 64.8000 20.5000 42.0000 24.44%
2000 53.3256 27.5000 92.5000 26.3000 33.7500 35.00%
1999 43.1983 38.1000 67.8000 23.7500 25.0000 -39.47%
1998 50.4484 60.0000 86.9000 16.9000 41.3000 -29.76%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.160B $0.060B
Palatin Technologies, Inc is a development-stage medical technology companyinvolved in developing and commercializing products and technologies fordiagnostic imaging, cancer therapy and ethical drug development These developments are based on its proprietary monoclonal antibody radiolabeling and enabling peptide platform technologies.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $134.042B 15.44
CSL (CSLLY) Australia $95.565B 0.00
Gilead Sciences (GILD) United States $79.894B 9.90
Vertex Pharmaceuticals (VRTX) United States $58.903B 60.12
Biogen (BIIB) United States $50.188B 8.61
Illumina (ILMN) United States $46.978B 51.54
Regeneron Pharmaceuticals (REGN) United States $37.910B 16.60
Alexion Pharmaceuticals (ALXN) United States $23.295B 11.51
Seattle Genetics (SGEN) United States $19.464B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.134B 0.00
Incyte (INCY) United States $16.530B 38.37
BioMarin Pharmaceutical (BMRN) United States $15.475B 0.00
Genmab (GNMSF) Denmark $14.016B 61.91
Alnylam Pharmaceuticals (ALNY) United States $13.379B 0.00
Galapagos (GLPG) Belgium $12.683B 32.68
Exact Sciences (EXAS) United States $11.629B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $9.989B 0.00
Sarepta Therapeutics (SRPT) United States $8.378B 0.00
Bio-Techne Corp (TECH) United States $8.193B 54.84
BioNTech SE (BNTX) Germany $7.917B 0.00
QIAGEN (QGEN) Netherlands $7.884B 25.71
Guardant Health (GH) United States $7.516B 0.00
Amarin (AMRN) Ireland $7.223B 0.00
Moderna (MRNA) United States $7.038B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.754B 17.17
ACADIA Pharmaceuticals (ACAD) United States $6.059B 0.00
Reata Pharmaceuticals (RETA) United States $5.857B 0.00
Ascendis Pharma (ASND) Denmark $5.722B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.516B 0.00
Exelixis (EXEL) United States $5.475B 15.40
Repligen (RGEN) United States $5.160B 93.50
Bluebird Bio (BLUE) United States $4.828B 0.00
China Biologic Products (CBPO) China $4.540B 25.58
MorphoSys AG (MOR) Germany $4.157B 0.00
Adaptive Biotechnologies (ADPT) United States $3.799B 0.00
Mirati Therapeutics (MRTX) United States $3.588B 0.00
Immunomedics (IMMU) United States $3.535B 0.00
NeoGenomics (NEO) United States $3.372B 179.44
Ultragenyx Pharmaceutical (RARE) United States $3.291B 0.00
Blueprint Medicines (BPMC) United States $3.227B 0.00
MyoKardia (MYOK) United States $3.188B 0.00
Zai Lab (ZLAB) China $3.181B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.164B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.022B 0.00
Genmab (GMAB) Denmark $2.906B 5.99
Emergent Biosolutions (EBS) United States $2.892B 28.73
Halozyme Therapeutics (HALO) United States $2.795B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.790B 0.00
Alkermes (ALKS) Ireland $2.776B 0.00
Acceleron Pharma (XLRN) United States $2.763B 0.00
UniQure (QURE) Netherlands $2.710B 0.00
Denali Therapeutics (DNLI) United States $2.367B 0.00
Amicus Therapeutics (FOLD) United States $2.278B 0.00
Arena Pharmaceuticals (ARNA) United States $2.230B 5.19
RA PHARMCTL INC (RARX) United States $2.205B 0.00
Myriad Genetics (MYGN) United States $2.129B 31.45
Epizyme (EPZM) United States $2.040B 0.00
Principia Biopharma (PRNB) United States $1.876B 0.00
Zymeworks (ZYME) Canada $1.868B 0.00
Fate Therapeutics (FATE) United States $1.826B 0.00
Insmed (INSM) United States $1.795B 0.00
Akcea Therapeutics (AKCA) United States $1.700B 0.00
Alector (ALEC) United States $1.692B 0.00
Arvinas (ARVN) United States $1.690B 0.00
REGENXBIO (RGNX) United States $1.619B 0.00
Ligand Pharmaceuticals (LGND) United States $1.555B 29.91
Editas Medicine (EDIT) United States $1.454B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.318B 0.00
Intra-Cellular Therapies (ITCI) United States $1.308B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.276B 0.00
Coherus BioSciences (CHRS) United States $1.273B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.270B 0.00
Zealand Pharma (ZEAL) Denmark $1.153B 0.00
Athenex (ATNX) United States $1.111B 0.00
Mesoblast (MESO) Australia $1.060B 0.00
DBV Technologies S.A (DBVT) France $1.012B 0.00
Codexis (CDXS) United States $0.988B 0.00
Revance Therapeutics (RVNC) United States $0.982B 0.00
PHARMA MAR SA (PHMMF) Spain $0.945B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.937B 0.00
Pharming Group (PHGUF) Netherlands $0.909B 0.00
Sangamo Therapeutics (SGMO) United States $0.870B 0.00
Heska (HSKA) United States $0.813B 207.72
ZIOPHARM Oncology Inc (ZIOP) United States $0.800B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.762B 6.41
Vericel (VCEL) United States $0.752B 280.33
ANI Pharmaceuticals (ANIP) United States $0.744B 12.68
Adverum Biotechnologies (ADVM) United States $0.740B 0.00
GENFIT S.A (GNFT) France $0.729B 0.00
Twist Bioscience (TWST) United States $0.720B 0.00
Sorrento Therapeutics (SRNE) United States $0.717B 0.00
Cytokineticsorporated (CYTK) United States $0.710B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.708B 0.00
Retrophin (RTRX) United States $0.701B 0.00
Cellectis S.A (CLLS) France $0.696B 0.00
Intellia Therapeutics (NTLA) United States $0.675B 0.00
Cara Therapeutics (CARA) United States $0.642B 0.00
NantKwest (NK) United States $0.642B 0.00
UROGEN PHARMA (URGN) United States $0.636B 0.00
Anika Therapeutics (ANIK) United States $0.626B 20.32
AC Immune SA (ACIU) Switzerland $0.584B 13.50
Kadmon Holdings (KDMN) United States $0.580B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Prothena (PRTA) Ireland $0.523B 0.00
Agenus (AGEN) United States $0.519B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.515B 0.00
BioDelivery Sciences (BDSI) United States $0.515B 0.00
Precision BioSciences (DTIL) United States $0.504B 0.00
Clovis Oncology (CLVS) United States $0.489B 0.00
Bellus Health (BLU) Canada $0.487B 0.00
Dynavax Technologies (DVAX) United States $0.485B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.430B 0.00
Inovio Pharmaceuticals (INO) United States $0.424B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.410B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.401B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.392B 0.00
Avid Bioservices (CDMO) United States $0.389B 0.00
AnaptysBio (ANAB) United States $0.380B 0.00
Kindred Biosciences (KIN) United States $0.371B 0.00
PDL BioPharma (PDLI) United States $0.371B 9.29
MannKind (MNKD) United States $0.363B 0.00
OSMOTICA PHARM (OSMT) United States $0.361B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.357B 2.47
Mersana Therapeutics (MRSN) United States $0.355B 0.00
Cue Biopharma (CUE) United States $0.350B 0.00
Gritstone Oncology (GRTS) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Stemline Therapeutics (STML) United States $0.339B 0.00
Compugen (CGEN) Israel $0.339B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.327B 0.00
Puma Biotechnology (PBYI) United States $0.316B 0.00
Syros Pharmaceuticals (SYRS) United States $0.307B 0.00
Starpharma Holdings (SPHRY) Australia $0.304B 0.00
POXEL SA FRANCE (PXXLF) France $0.303B 0.00
Albireo Pharma (ALBO) United States $0.294B 0.00
IVERIC Bio (ISEE) United States $0.291B 0.00
Kamada (KMDA) Israel $0.273B 7.96
Geron (GERN) United States $0.272B 0.00
WAVE Life Sciences (WVE) Singapore $0.259B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
ADMA Biologics Inc (ADMA) United States $0.253B 0.00
Biofrontera AG (BFRA) Germany $0.252B 0.00
Novavax (NVAX) United States $0.251B 0.00
ChromaDex (CDXC) United States $0.248B 0.00
Prometic Life Sciences (LMNL) Canada $0.245B 0.00
VBI Vaccines (VBIV) United States $0.228B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Seres Therapeutics (MCRB) United States $0.219B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.214B 0.00
Theratechnologies (THTX) Canada $0.214B 0.00
Athersys (ATHX) United States $0.212B 0.00
Exicure (XCUR) United States $0.209B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.209B 0.00
Protagonist Therapeutics (PTGX) United States $0.205B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.204B 0.00
Cerecor (CERC) United States $0.203B 0.00
XOMA (XOMA) United States $0.203B 0.00
Five Prime Therapeutics (FPRX) United States $0.203B 0.00
Aptinyx (APTX) United States $0.195B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.191B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.190B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Fortress Biotech (FBIO) United States $0.185B 0.00
Arbutus Biopharma (ABUS) Canada $0.180B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
TELA Bio (TELA) United States $0.177B 0.00
Alcobra (ARCT) United States $0.177B 0.00
Strongbridge Biopharma (SBBP) United States $0.170B 4.54
Windtree Therapeutics (WINT) United States $0.161B 0.00
ARAVIVE, INC (ARAV) United States $0.157B 0.00
PHASEBIO PHARMA (PHAS) United States $0.152B 0.00
Selecta Biosciences (SELB) United States $0.148B 0.00
Dyadic (DYAI) United States $0.142B 0.00
Verastem (VSTM) United States $0.139B 0.00
Applied Genetic Technologies (AGTC) United States $0.135B 0.00
Abeona Therapeutics (ABEO) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.134B 0.00
VTv Therapeutics (VTVT) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.123B 0.00
Clearside Biomedical (CLSD) United States $0.123B 0.00
Liquidia Technologies (LQDA) United States $0.122B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
Happiness Biotech Group (HAPP) China $0.118B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.117B 0.00
Arsanis (XFOR) United States $0.116B 0.00
OvaScience (MLND) United States $0.112B 0.00
Antibe Therapeutics (ATBPF) Canada $0.110B 0.00
Celyad SA (CYAD) Belgium $0.110B 0.00
Vaccinex (VCNX) United States $0.102B 0.00
Acorda Therapeutics (ACOR) United States $0.101B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.095B 0.00
SESEN BIO, INC (SESN) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
Trevena (TRVN) United States $0.090B 0.00
Proteostasis Therapeutics (PTI) United States $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Catalyst Biosciences (CBIO) United States $0.081B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
Orgenesis (ORGS) United States $0.079B 5.10
Prima BioMed (IMMP) Australia $0.078B 0.00
Emmaus Life Sciences (EMMA) United States $0.075B 0.00
Checkpoint Therapeutics (CKPT) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Soligenix (SNGX) United States $0.061B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Curis (CRIS) United States $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
DiaMedica Therapeutics (DMAC) United States $0.050B 0.00
Organovo Holdings (ONVO) United States $0.048B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
Celsion (CLSN) United States $0.035B 0.00
VistaGen Therapeutics (VTGN) United States $0.034B 0.00
BioCardia (BCDA) United States $0.034B 0.00
Unum Therapeutics (UMRX) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Signal Genetics (MGEN) United States $0.031B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.029B 0.00
VIVUS (VVUS) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.024B 0.00
Stellar Biotechnologies (EDSA) Canada $0.023B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Advaxis (ADXS) United States $0.015B 0.00
Cleveland BioLabs (CBLI) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00